The first patient has been dosed in a first-in-human clinical trial evaluating HLD-0915 for metastatic castration-resistant ...
A phase 1/2 trial is evaluating HLD-0915, a novel oral therapy, for metastatic castration-resistant prostate cancer in up to ...
Halda Therapeutics, a clinical-stage biotechnology company developing a novel class of cancer therapies called RIPTAC™ (Regulated Induced Proximity TArgeting Chimeras) therapeutics, today announced ...
Explore PERSHING SQ HLD LTD REG S by Pershing Square Holdings Ltd. stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PSHZF. Bill Ackman's Pershing Square ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback